Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1615 1631 1632
This examiner grants 62% of resolved cases
Titilayo Moloye is an examiner in Tech Center 1600 and Art Unit 1600. With a history of 554 resolved cases, the examiner maintains an allowance rate of 62.5 percent. This rate is higher than the 47.9 percent interview lift, providing a reliable indicator of typical outcomes. The median days to allowance is 1339, reflecting the duration for the patent grant process that applicants should prepare for.
The 47.9 percent interview lift is a high value for an examiner with 554 resolved cases. This lift suggests that interviews are a critical and effective component of a successful prosecution strategy. Practitioners can use this information to justify an interview to navigate the 1339-day median path to allowance. The 47.9 percent lift highlights the value of direct communication in overcoming rejections and securing a grant alongside the 62.5 percent base allowance rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17999756 | COMPOSITIONS AND METHODS FOR GENE EDITING | Non-Final OA | The Regents of the University of California |
| 18715569 | SELF-ASSEMBLING VIRUS-LIKE PARTICLES FOR DELIVERY OF NUCLEIC ACID PROGRAMMABLE FUSION PROTEINS AND METHODS OF MAKING AND USING SAME | Non-Final OA | President and Fellows of Harvard College |
| 18432439 | Biosensors in Human Gut Organoids | Final Rejection | Massachusetts Institute of Technology |
| 17219430 | PLURIPOTENT STEM CELL FOR TREATMENT OF CEREBRAL INFARCTION | Final Rejection | TOHOKU UNIVERSITY |
| 18699454 | STEREOCILIN PROMOTERS AND USES THEREOF | Non-Final OA | REGENERON PHARMACEUTICALS, INC. |
| 18915826 | METHODS FOR GENERATING AND USING ORGANOIDS AND TISSUE THEREIN | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 18060322 | SUBSTRATES AND BIOREACTORS FOR PREPARING A COMESTIBLE MEAT PRODUCT | Non-Final OA | Upside Foods, Inc. |
| 18004522 | ADENO-ASSOCIATED VIRUS VECTOR FOR DWARF OPEN READING FRAME | Final Rejection | The Board of Regents of The University of Texas System |
| 18000957 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING COAGULOPATHY AND/OR SEPSIS IN PATIENTS SUFFERING FROM BACTERIAL AND/OR VIRAL INFECTIONS | Final Rejection | YALE UNIVERSITY |
| 16992362 | THREE-DIMENSIONAL DIFFERENTIATION OF EPIBLAST SPHEROIDS TO KIDNEY ORGANOIDS MODELS STAGE-SPECIFIC EPITHELIAL PHYSIOLOGY, MORPHOGENESIS, AND DISEASE | Final Rejection | THE BRIGHAM AND WOMEN'S HOSPITAL, INC. |
| 18863725 | METHOD FOR COLLECTING STEM CELLS FROM ANIMAL TISSUE | Non-Final OA | OSAKA UNIVERSITY |
| 16969523 | Cell Mass Fusion Method | Final Rejection | Public University Corporation Yokohama City University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy